reference/6648365

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6648365

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
endingPage	787
issn	0305-1870 1440-1681
issueIdentifier	10
pageRange	780-787
publicationName	Clinical and Experimental Pharmacology and Physiology
startingPage	780
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f3691df2df4fb7245dd8ca89b0ffc35d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_276d9a57fa0bf8993ab06673ee571d4e
bibliographicCitation	Lopez AM, Terpack SJ, Posey KS, Liu B, Ramirez CM, Turley SD. Systemic administration of 2-hydroxypropyl-β-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function. Clin Exp Pharmacol Physiol. 2014 Oct;41(10):780–7. PMID: 25115571; PMCID: PMC4526211.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d7ccff7147c73cf8bf054d2c3a24d0f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39eb4cc02e0d83c15ff1950f3fb91b57 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afbed0b693fa7634464a545dbbda795d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c618619817763480bf8cb3a13678c141 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7202dc32033f087f90a7650d5b49086 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9a033c8ee956cdffc933af34be8d26d
date	201410
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC4526211 https://doi.org/10.1111/1440-1681.12285 https://pubmed.ncbi.nlm.nih.gov/25115571
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3003 https://portal.issn.org/resource/ISSN/0305-1870 https://portal.issn.org/resource/ISSN/1440-1681
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Systemic administration of 2‐hydroxypropyl‐β‐cyclodextrin to symptomatic Npc1‐deficient mice slows cholesterol sequestration in the major organs and improves liver function
discusses	http://id.nlm.nih.gov/mesh/M000640362 http://id.nlm.nih.gov/mesh/M0278209 http://id.nlm.nih.gov/mesh/M0152341 http://id.nlm.nih.gov/mesh/M0457481 http://id.nlm.nih.gov/mesh/M0017890 http://id.nlm.nih.gov/mesh/M0460178 http://id.nlm.nih.gov/mesh/M0004268
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008099Q000187 http://id.nlm.nih.gov/mesh/D011506Q000378 http://id.nlm.nih.gov/mesh/D052556Q000188 http://id.nlm.nih.gov/mesh/D002784Q000378 http://id.nlm.nih.gov/mesh/D047392Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000077296 http://id.nlm.nih.gov/mesh/D008111Q000379 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D047908 http://id.nlm.nih.gov/mesh/D008099Q000378 http://id.nlm.nih.gov/mesh/D009929Q000187 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D000073738 http://id.nlm.nih.gov/mesh/D052556Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10395 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.6.1.1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8666 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9975 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ea430576f3318b31bc2d5d5168d2e533 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44134771 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_711471f52cb1b6691925c61c80c22d4d

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18145

Total number of triples: 63.